Maravai Lifesciences Holdings, Inc. (MRVI)
3.10
+0.02
(+0.65%)
USD |
NASDAQ |
Feb 20, 16:00
3.105
0.00 (0.00%)
After-Hours: 20:00
Maravai Lifesciences Holdings EPS Diluted (Quarterly) : -0.1766 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 0.0558 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -45.06M |
| Revenue (Quarterly) | 41.63M |
| Total Expenses (Quarterly) | 67.19M |
| Enterprise Value | 760.35M |
| Gross Profit Margin (Quarterly) | 12.14% |
| Profit Margin (Quarterly) | -108.2% |
| Earnings Yield | -27.24% |
| Normalized Earnings Yield | -11.36 |